A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT06092112 · COMPLETED
Trial details
- NCT number
- NCT06092112
- Sponsor
- Shanghai Changzheng Hospital
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-13
- Primary completion
- 2024-04-29
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.